Patent · US Active

Genetically modified mice expressing humanized CD47

US11723348B2 · kind B2 · utility

0Cited by

6References

13Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yang Bai · Beijing, CN
Jian Ni · Rockville, US
Rui Huang · Beijing, CN
Chengzhang Shang · Beijing, CN
Yanan Guo · Beijing, CN

Key dates

Filing date	Nov 2, 2020
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Sep 13, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD47, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.